US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ホーム
投資
株式
オーストラリア
ASX
Cleo Diagnostics Ltd (COV) 銘柄情報

Cleo Diagnostics Ltd (COV)

0.51

-0.01

( -1.92% )

更新日時： 11:54:05

Cleo Diagnostics Ltd (COV) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.51

( -1.92% )

買値

0.50

売値

0.525

出来高

73,618

0.50 日の範囲 0.51

0.335 52 週間の範囲 0.90

時価総額

前日終値

0.52

始値

0.51

時刻

最終取引時間

11:35:53

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 169,467

発行済株式数

136,862,085

配当利回り

PER

-16.42

1 株当たり利益 (EPS)

-0.03

歳入

2.56M

純利益

-4.03M

Cleo Diagnostics Ltd, a biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determi... Cleo Diagnostics Ltd, a biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.cleodx.com

本社

Melbourne, Australia

設立

2026

Cleo Diagnostics Ltd is listed in the sector of the オーストラリア証券取引所 with ticker COV. The last closing price for Cleo Diagnostics was AUD0.52. Over the last year, Cleo Diagnostics shares have traded in a share price range of AUD 0.335 to AUD 0.90.

Cleo Diagnostics currently has 136,862,085 shares in issue. The market capitalisation of Cleo Diagnostics is AUD69.80 million. Cleo Diagnostics has a price to earnings ratio (PE ratio) of -16.42.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.055	-9.73451327434	0.565	0.565	0.5	69699	0.52860095	DE
4	-0.18	-26.0869565217	0.69	0.7	0.5	150223	0.61160409	DE
12	0.035	7.36842105263	0.475	0.75	0.4575	167011	0.59203826	DE
26	-0.14	-21.5384615385	0.65	0.9	0.4575	245464	0.6302497	DE
52	0.155	43.661971831	0.355	0.9	0.335	210260	0.55503692	DE
156	0.28	121.739130435	0.23	0.9	0.14	169086	0.43238344	DE
260	0.28	121.739130435	0.23	0.9	0.14	169086	0.43238344	DE

COV - Frequently Asked Questions (FAQ)

What is the current Cleo Diagnostics Ltd share price?

The current share price of Cleo Diagnostics Ltd is AUD 0.51

How many Cleo Diagnostics Ltd shares are in issue?

Cleo Diagnostics Ltd has 136,862,085 shares in issue

What is the market cap of Cleo Diagnostics Ltd?

The market capitalisation of Cleo Diagnostics Ltd is AUD 69.8M

What is the 1 year trading range for Cleo Diagnostics Ltd share price?

Cleo Diagnostics Ltd has traded in the range of AUD 0.335 to AUD 0.90 during the past year

What is the PE ratio of Cleo Diagnostics Ltd?

The price to earnings ratio of Cleo Diagnostics Ltd is -16.42

What is the cash to sales ratio of Cleo Diagnostics Ltd?

The cash to sales ratio of Cleo Diagnostics Ltd is 27.51

What is the registered address of Cleo Diagnostics Ltd?

The registered address for Cleo Diagnostics Ltd is 480 Collins Street, Melbourne, Victoria, 3000

What is the Cleo Diagnostics Ltd website address?

The website address for Cleo Diagnostics Ltd is www.cleodx.com

Juststoppingby

Juststoppingby 6分前

It would not be good for us if Endurion was not working, but I am reasonably sure it is working well.
I would like to know which phase they are in: have they already signed a JDA, do they have multiple partners (multiple partners would mean multiple OEMs), or did they fall for just one partne

Just give me $1.50

Just give me $1.50 9分前

Hahahahahahaha!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

March 06, 2026

Subject: Shareholder Suggestion: Timing of Potential M&A Announcements

Dear Ms. Will,

I hope this email finds you well.

As a long-term shareholder of Elite Pharm

mdb1

DOWN she goes .....

US Market News

US Market News 10分前

Natalia Dyer Explores Korean Beauty Culture, Unveiling Authentic Charm on SetJune 10, 2026 1:05 AM
PR Newswire (US) class="legendSpanClass"NEW YORK, class="legendSpanClass"June 10, 2026 /PRNewswire/ -- Natalia Dyer has recently developed

mdb1

IQST could dip into the $.70s the "selloff" seems to continue.
I expect IQST mgt will buy it back to over $1 even if it means buying millions of shares.

I-Glow

I-Glow 12分前

This is the hijacked shell where he told investors he was going to lead them to the promised land.

IG

OracleWitch66

OracleWitch66 13分前

To Bad this not like they used to be. Late night chatter bout how much its going to go up next morning!!! Im bored

tweedking

tweedking 14分前

Perhaps im reading into this too much but why is a Director/Hedge fund manager holding the signed contract for Delfin when the CEO is right there? Seems odd to me since the Vice Chairman of Samsung is representing on his side.

I-Glow

I-Glow 17分前

This is hilarious - "As of now, George A. Sharp is alive and continues to participate in corporate activities concerning GVSI and WNFT."

5 years and Sharp understands that GVSI is a Zombie ticker and after 5 years GOFF/WNFT is still a shell.

So what are the corporate

Just give me $1.50

Just give me $1.50 18分前

Hahahahahahaha!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

June 03, 2026

"We are moving up"

JusticeWillWin

JusticeWillWin 19分前

Again >2M traded at the close...

JusticeWillWin

JusticeWillWin 19分前

Grok's comment:

Bottom line for shareholders

This is standard corporate finance housekeeping — not transformative growth news. It’s positive for balance sheet stability (especially post-acquisitions) but adds to costs at a time when the business is already navigating hi

vinmantoo

vinmantoo 20分前

They will leverage the factors to prove that the immense revenue was driven by Pfizer's unprecedented global manufacturing scale and risk-taking during a public health emergency, not just Enanta's chemical compound

Why would that matter if they impinged on ENTA's patent?

janice shell

janice shell 25分前

If you want to add to the real estate list, he told me he had a condo in New York.

I-Glow

I-Glow 29分前

You never read any filings and here are the facts.
I suspected he was pushed out, and the SEC filings completely validate that.
?Castellum (NYSE-American: CTM) filed an 8-K stating that Wright "resigned" effective December 31, 2025. While corporate PR always uses the standard "no disp

Toronto_Trader

Toronto_Trader 31分前

The OTCM data is messed up. The ~149M unrestricted common shares were posted on December 9/25 and the 20M restricted common shares were posted Feb 25/26. No share issuance has occured since.

The exception being the 200M for the Kendrick deal, due to close within the next 3 weeks and s

Flip it

Flip it 32分前

You know your technology, no question about it.

Very clear

shajandr

shajandr 40分前

"He would be way too young for that."
Dude ... dude ... George was 66 years old. That is nott "way too young to die".

CANCER CHARLIE was 60 when he stopped circulating hemoglobin-containing envelopes, and he lived seven (7) years after diagnosis. His widowed wife is 61 and has

Helter Skelter

Helter Skelter 40分前

AI Overview 👉️ Yes, Malikie keeps its first $200 million in gross recoveries, and BlackBerry (BB) only begins receiving a percentage of the profits after Malikie is "made whole".

What date did these 4 settlements happen?

AI

rcbindustry

rcbindustry 40分前

The sentiment around AVXL seems extremely negative right now, which is often when biotech stocks become the most interesting to watch. There are still plenty of unanswered questions, but I think the next meaningful update from management will be more important than the daily share price fluctuations

wildwertski

wildwertski 43分前

The changes look good, but are simply cosmetic. It’s still the same app it was before. Still waiting for the most basic problems to be fixed. I guess we’ll just have to wait and see. Hope he comes through and something good happens. Best to all,WW

MartinLutherKing

MartinLutherKing 44分前

Oh Hell Yes something is brewing alright, Let’s all hold hands and pray for news$$$

100lbStriper

100lbStriper 46分前

i called it would break 30mil short, now it looks like they want 40mil.......anything really significant comes out and this will sky rocket!!!

Uncleteddy

Uncleteddy 48分前

You also forgot to mention that it is highly speculated that Talisman Group (hedge fund) created and used SPV to acquire more than the 71% of TGLO that delfin already owns. Which leads everyone to believe the float is much smaller than it appears on the surface

cottonisking

cottonisking 49分前

⏰️🐎🐎🐎 How has a recent Supreme Court ruling shifted SEC disgorgement powers in a bankruptcy case? The June 2026 Supreme Court ruling as it relates to LBHI's bankruptcy.

The U.S. Supreme Court did not rule on a case combining both Securities and Exchange Commiss

Cleo Diagnostics

Binovi Technologies

Kesko OYJ Wertpapieren (PK)

Wisdomtree Energy Transi...

BlackRock Institutional ...

Genetic Technologies

Axiom Balanced Income Po...

Delta Electronics Thaila... (PK)

Alaska Hydro (EM)

Old Market Capital

Sweet Poison Spirits

Amundi MSCI World SRI Cl...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。